SINGLE-CENTER PARALLEL-GROUP TRIAL WITH AN OPEN-LABEL AND TWO TREATMENT ARMS, TO EVALUATE THE EFFICACY AND SAFETY OF 16-WEEKS OF INJECTION ADMINISTRATION OF ITV-1- IMMUNH IN COMBINATION WITH AN ANTIRETROVIRAL THERAPY IN HIV-POSITIVE PATIENTS WITH ADVANCED AIDS

Trial Profile

SINGLE-CENTER PARALLEL-GROUP TRIAL WITH AN OPEN-LABEL AND TWO TREATMENT ARMS, TO EVALUATE THE EFFICACY AND SAFETY OF 16-WEEKS OF INJECTION ADMINISTRATION OF ITV-1- IMMUNH IN COMBINATION WITH AN ANTIRETROVIRAL THERAPY IN HIV-POSITIVE PATIENTS WITH ADVANCED AIDS

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Dec 2016

At a glance

  • Drugs ITV 1 (Primary) ; Antiretrovirals
  • Indications HIV infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Dec 2016 New trial record
    • 23 Nov 2016 Results (full and detailed clinical trials Final Report) published in an Immunotech Laboratories BG media release.
    • 30 Jul 2016 According to an Immunotech Laboratories BG media release, the full and detailed clinical trials Final Report is expected very soon.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top